Search results: found 7 materials

Rostec has Delivered 8.48 million Vaccine Doses to Russian Regions
15 Mar 2024

Rostec has Delivered 8.48 million Vaccine Doses to Russian Regions

Russian medical facilities have received drug products for protection against pertussis, tetanus, diphtheria, hepatitis B, tuberculosis and rubella

Rostec to Deliver 800,000 Measles Vaccine Doses to the Russian Regions
14 Mar 2023

Rostec to Deliver 800,000 Measles Vaccine Doses to the Russian Regions

The campaign is focused on the immunization of social groups not covered by the standard vaccination procedure

Natsimbio is Launching a New Drug for the Treatment of Immunodeficiencies
14 Dec 2022

Natsimbio is Launching a New Drug for the Treatment of Immunodeficiencies

BioGam drug will substitute for its foreign analogues and increase the availability and quality of therapy

The Human Stem Cell Institute and Rostec are Developing Influenza and COVID-19 Vaccine
20 Jun 2022

The Human Stem Cell Institute and Rostec are Developing Influenza and COVID-19 Vaccine

Clinical study of the combination vaccine formulation is to be started in the second half of the year

Microgen Developed Drug for ICP Treatment
14 Dec 2017

Microgen Developed Drug for ICP Treatment

The first Russian made drug for cerebral palsy caused spastic ailment treatment is abreast with the oversees counterparts

Nacimbio to Showcase Key Projects and New Development
8 Dec 2017

Nacimbio to Showcase Key Projects and New Development

The pharmaceutical holding company participates in the “PharmMedProm-2017” exhibition

Nacimbio Participated in Panel Discussions at the BIOTECHMED
19 Sep 2017

Nacimbio Participated in Panel Discussions at the BIOTECHMED

Special attention was paid to the need for transition to multicomponent prophylactic drugs